Biotechnology - Biotechnology, Oxford BioMedica


Popular Filters

Oxford BioMedica gets US and French go-ahead to resume recruitment into ocular clinical trials


Oxford BioMedica has received agreement from the US Food and Drug Administration and the French regulatory…

BiotechnologyEuropeOphthalmicsOxford BioMedicaRegulationResearch

Oxford BioMedica earns Pfizer milestone


UK, gene-based biopharma company Oxford BioMedica (LSE: OXB) says it has received a $1 million milestone…

BiotechnologyFinancialOncologyOxford BioMedicaPF-06263507PfizerResearch

Oxford BioMedica to close US trial of TroVax due to "changing landscape"


UK gene-based biopharma company Oxford BioMedica (LSE: OXB) says that it plans to close the Phase II…

BiotechnologyOncologyOxford BioMedicaResearchTroVaxVaccines

Oxford BioMedica in glaucoma R&D accord with Mayo Clinic


UK-based Oxford BioMedica (LSE: OXB) has entered into an R&D collaboration with the USA’s Mayo Clinic…

BiotechnologyLicensingOphthalmicsOxford BioMedicaPharmaceuticalResearchSanofi

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top